Kimberly-Clark agrees to buy Tylenol maker Kenvue in a cash-and-stock deal valued at about $48.7 billion, including debt.
Kimberly-Clark (KMB 12.24%) stock tumbled 12.5% through 10:25 a.m. ET Monday, and it's not hard to figure out why. This ...
Shares of Kimberly-Clark Corporation (NASDAQ: KMB) plunged 16.49% during the pre-market trading session on Monday, after it ...
Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive ...
If you find yourself weighing whether to hold, buy, or simply keep an eye on Kimberly-Clark, you are not alone. Investors ...
Discover why Kimberly-Clark Corporation could be a smart buy now with its improved valuation and highest dividend yield in ...